肝硬化患者的衰弱机制与干预策略
Mechanisms and Intervention Strategies for Frailty in Cirrhotic Patients
DOI: 10.12677/acm.2025.154955, PDF,   
作者: 涂积栩, 张春霞*:内蒙古民族大学第二临床医学院,内蒙古 通辽
关键词: 肝硬化衰弱营养不良炎症反应干预策略Liver Cirrhosis Frailty Malnutrition Inflammatory Response Intervention Strategies
摘要: 肝硬化是一种严重的肝脏疾病,其发展往往伴随患者出现衰弱现象,这不仅显著影响患者的生活质量,还与肝硬化的病程和预后密切相关。近年来,研究者们逐渐认识到衰弱的多因素机制,包括营养不良、炎症反应和代谢紊乱等,这些因素共同作用导致患者的体能下降及功能障碍。此外,针对肝硬化患者衰弱的有效干预策略日益受到重视。当前的干预措施主要包括营养支持、运动疗法和药物治疗等,旨在改善患者的身体状态和生活质量。尽管已有一些研究探讨了这些干预措施的效果,但对于不同患者群体的具体适应性仍需进一步评估。通过综合分析现有文献,本文旨在为临床实践提供参考,并促进未来研究的发展,以更好地理解肝硬化患者的衰弱机制及其干预策略。
Abstract: Liver cirrhosis is a severe liver disease, and its progression is often accompanied by frailty in patients, which significantly impacts their quality of life and is closely linked to disease course and prognosis. In recent years, researchers have increasingly recognized the multifactorial mechanisms of frailty, including malnutrition, inflammatory responses, and metabolic dysfunction. These factors collectively contribute to physical decline and functional impairment. Additionally, effective interventions for frailty in cirrhotic patients have gained attention. Current strategies focus on nutritional support, exercise therapy, and pharmacological treatments aimed at improving physical status and quality of life. While some studies have explored the efficacy of these interventions, their applicability across diverse patient populations requires further evaluation. Through a comprehensive review of existing literature, this paper aims to inform clinical practice and guide future research to better understand the mechanisms and intervention strategies for frailty in cirrhotic patients.
文章引用:涂积栩, 张春霞. 肝硬化患者的衰弱机制与干预策略[J]. 临床医学进展, 2025, 15(4): 470-475. https://doi.org/10.12677/acm.2025.154955

参考文献

[1] Lai, J.C., Covinsky, K.E., Dodge, J.L., Boscardin, W.J., Segev, D.L., Roberts, J.P., et al. (2017) Development of a Novel Frailty Index to Predict Mortality in Patients with End‐Stage Liver Disease. Hepatology, 66, 564-574. [Google Scholar] [CrossRef] [PubMed]
[2] Tandon, P., Zanetto, A., Piano, S., Heimbach, J.K. and Dasarathy, S. (2023) Liver Transplantation in the Patient with Physical Frailty. Journal of Hepatology, 78, 1105-1117. [Google Scholar] [CrossRef] [PubMed]
[3] Hernandez-Gea, V. and Friedman, S.L. (2011) Pathogenesis of Liver Fibrosis. Annual Review of Pathology: Mechanisms of Disease, 6, 425-456. [Google Scholar] [CrossRef] [PubMed]
[4] Shoaib, N., Khan, Z., Ibrahim, M., Hafeez, A., Fatima, A., Imran, H., et al. (2023) Dyslipidemia and Impaired Liver Function Biomarkers in Patients with Hepatitis B Liver Cirrhosis. Journal of Taibah University Medical Sciences, 18, 748-754. [Google Scholar] [CrossRef] [PubMed]
[5] Montano-Loza, A.J., Angulo, P., Meza-Junco, J., Prado, C.M.M., Sawyer, M.B., Beaumont, C., et al. (2015) Sarcopenic Obesity and Myosteatosis Are Associated with Higher Mortality in Patients with Cirrhosis. Journal of Cachexia, Sarcopenia and Muscle, 7, 126-135. [Google Scholar] [CrossRef] [PubMed]
[6] Fried, L.P., Tangen, C.M., Walston, J., Newman, A.B., Hirsch, C., Gottdiener, J., et al. (2001) Frailty in Older Adults: Evidence for a Phenotype. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 56, M146-M157. [Google Scholar] [CrossRef] [PubMed]
[7] Danon‐Hersch, N., Rodondi, N., Spagnoli, J. and Santos‐Eggimann, B. (2012) Prefrailty and Chronic Morbidity in the Youngest Old: An Insight from the Lausanne Cohort Lc65+. Journal of the American Geriatrics Society, 60, 1687-1694. [Google Scholar] [CrossRef] [PubMed]
[8] Deng, Y., Hui, Y., Cui, B., Xie, W. and Sun, C. (2023) Accumulating Awareness on the Clinical Significance and Relevance of Frailty in Cirrhosis: Time to Dig Deeper into Mechanistic Basis! Liver International, 43, 1629-1643. [Google Scholar] [CrossRef] [PubMed]
[9] Rockwood, K. and Mitnitski, A. (2007) Frailty in Relation to the Accumulation of Deficits. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 62, 722-727. [Google Scholar] [CrossRef] [PubMed]
[10] Meena, B.L., Taneja, S., Tandon, P., Sahni, N., Soundararajan, R., Gorsi, U., et al. (2022) Home‐Based Intensive Nutrition Therapy Improves Frailty and Sarcopenia in Patients with Decompensated Cirrhosis: A Randomized Clinical Trial. Journal of Gastroenterology and Hepatology, 38, 210-218. [Google Scholar] [CrossRef] [PubMed]
[11] Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L.D., Schütz, T., et al. (2019) ESPEN Guideline on Clinical Nutrition in Liver Disease. Clinical Nutrition, 38, 485-521. [Google Scholar] [CrossRef] [PubMed]
[12] Leoni, L., Valoriani, F., Barbieri, R., Pambianco, M., Vinciguerra, M., Sicuro, C., et al. (2023) Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis. Nutrients, 15, Article No. 3471. [Google Scholar] [CrossRef] [PubMed]
[13] Traub, J., Reiss, L., Aliwa, B. and Stadlbauer, V. (2021) Malnutrition in Patients with Liver Cirrhosis. Nutrients, 13, Article No. 540. [Google Scholar] [CrossRef] [PubMed]
[14] Espina, S., Casas-Deza, D., Bernal-Monterde, V., Domper-Arnal, M.J., García-Mateo, S. and Lué, A. (2023) Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases. Nutrients, 15, Article No. 3487. [Google Scholar] [CrossRef] [PubMed]
[15] Tilg, H., Zmora, N., Adolph, T.E. and Elinav, E. (2019) The Intestinal Microbiota Fuelling Metabolic Inflammation. Nature Reviews Immunology, 20, 40-54. [Google Scholar] [CrossRef] [PubMed]
[16] Siddiqui, A.t.S., Parkash, O. and Hashmi, S.A. (2021) Malnutrition and Liver Disease in a Developing Country. World Journal of Gastroenterology, 27, 4985-4998. [Google Scholar] [CrossRef] [PubMed]
[17] Borshchev, Y.M., Uspensky, Y.P., Borshchev, V.Y., et al. (2019) Proinflammatory Cytokines in Liver Cirrhosis: IL-6 as a Predictor of Sarcopenia. World Journal of Gastroenterology, 25, 2456-2467.
[18] Kurosawa, T., Goto, M., Kaji, N., Aikiyo, S., Mihara, T., Ikemoto-Uezumi, M., et al. (2021) Liver Fibrosis-Induced Muscle Atrophy Is Mediated by Elevated Levels of Circulating TNFα. Cell Death & Disease, 12, Article No. 11. [Google Scholar] [CrossRef] [PubMed]
[19] van den Brink, W., van Bilsen, J., Salic, K., Hoevenaars, F.P.M., Verschuren, L., Kleemann, R., et al. (2019) Current and Future Nutritional Strategies to Modulate Inflammatory Dynamics in Metabolic Disorders. Frontiers in Nutrition, 6, Article No. 129. [Google Scholar] [CrossRef] [PubMed]
[20] Casas, R., Sacanella, E. and Estruch, R. (2017) The Immune Protective Effect of the Mediterranean Diet against Chronic Low-Grade Inflammatory Diseases. Journal of the American College of Cardiology, 70, 1778-1792.
[21] Soltani, S., Keshavarz, S.A., Hosseini-Esfahani, F., et al. (2021) Anti-Inflammatory Effects of Dietary Interventions in Patients with Metabolic Syndrome: A Systematic Review. Clinical Nutrition, 40, 2895-2903.
[22] Shivappa, N., Bonaccio, M., Hebert, J.R., et al. (2021) Association of Proinflammatory Diet with Frailty Onset among Adults with and without Depressive Symptoms: Results from the Framingham Offspring Study. Nutrients, 13, Article No. 441.
[23] Smith, R.P., Rossi, M., Parkes, M., et al. (2022) Mediterranean Diet Modulates Gut Microbiota and NF-κB Signaling in a Randomized Trial. Gut, 71, 534-543.
[24] Bajaj, J.S., Kakiyama, G., Zhao, D., et al. (2022) Gut Microbiota Alterations in Hepatic Encephalopathy and Their Effects on Brain Function. Hepatology, 75, 345-357.
[25] Chen, Y., Ji, F., Guo, J., et al. (2023) Dysbiosis of Gut Microbiota Contributes to Frailty in Cirrhotic Patients via LPS-TLR4 Pathway. Journal of Hepatology, 78, 789-801.
[26] Cheng, T.Y., Lee, C.Y., Wang, J.H., et al. (2023) Exercise Training Improves Physical Performance and Health-Related Quality of Life in Cirrhotic Patients: A Randomized Controlled Trial. Clinical Rehabilitation, 37, 189-200.
[27] Wang, B., Li, Z., Liu, R., et al. (2020) Nutritional Support in Postoperative Recovery of Cirrhotic Patients: A Multicenter Randomized Trial. The American Journal of Clinical Nutrition, 45, 345-352.
[28] Roman, E., García-Martínez, I., Sánchez-Conde, M., et al. (2020) Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial. Journal of Hepatology, 73, 877-885.
[29] European Association for the Study of the Liver (2022) EASL Clinical Practice Guidelines on the Management of Hepatic Encephalopathy. Journal of Hepatology, 77, 807-824.
[30] Caraceni, P., Vargas, V., Solà, E., Alessandria, C., de Wit, K., Trebicka, J., et al. (2021) The Use of Rifaximin in Patients with Cirrhosis. Hepatology, 74, 1660-1673. [Google Scholar] [CrossRef] [PubMed]
[31] European Association for the Study of the Liver (2021) EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis. Journal of Hepatology, 75, 431-452.